Citation: B. Angrist et al., Commentary on: "Differential effects of amphetamine and neuroleptics on negative vs. positive symptoms in schizophrenia." - Psychopharmacology (1980)72, 17-19, PSYCHOPHAR, 158(3), 2001, pp. 219-221
Authors:
Duncan, EJ
Madonick, SH
Parwani, A
Angrist, B
Rajan, R
Chakravorty, S
Efferen, TR
Szilagyi, S
Stephanides, M
Chappell, PB
Gonzenbach, S
Ko, GN
Rotrosen, JP
Citation: Ej. Duncan et al., Clinical and sensorimotor gating effects of ketamine in normals, NEUROPSYCH, 25(1), 2001, pp. 72-83
Citation: B. Angrist et al., Cardiovascular effects of 0.5 milligrams per kilogram oral d-amphetamine and possible attenuation by haloperidol, CLIN NEUROP, 24(3), 2001, pp. 139-144
Authors:
Yui, K
Goto, K
Ikemoto, S
Ishiguro, T
Angrist, B
Duncan, GE
Sheitman, BB
Lieberman, JA
Bracha, SH
Ali, SF
Citation: K. Yui et al., Neurobiological basis of relapse prediction in stimulant-induced psychosisand schizophrenia: the role of sensitization, MOL PSYCHI, 4(6), 1999, pp. 512-523
Authors:
Volkow, ND
Wang, GJ
Fowler, JS
Hitzemann, R
Angrist, B
Gatley, SJ
Logan, J
Ding, YS
Pappas, N
Citation: Nd. Volkow et al., Association of methylphenidate-induced craving with changes in right striato-orbitofrontal metabolism in cocaine abusers: Implications in addiction, AM J PSYCHI, 156(1), 1999, pp. 19-26